Zum Hauptinhalt springen

Buprenorphin

08. Oktober 2021 | Buprenorphin

Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail.

Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail. Lee JD, Malone M, McDonald R, Cheng A, Vasudevan K, Tofighi…

08. Oktober 2021 | Buprenorphin

Retrospective analysis of heroin detoxification with buprenorphine in a psychiatric hospital in Japan.

Retrospective analysis of heroin detoxification with buprenorphine in a psychiatric hospital in Japan. Nagano T, Kimoto S, Aso K, Komori T, Yamaguchi Y, Okamura K, Yamamoto N, Kishimoto T. Neuropsychopharmacol Rep. 2020 Dec;40(4):376-3…

06. Oktober 2021 | Buprenorphin

Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel

Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel Kohan L, Potru S, Barreveld AM, et al Regional Anesthesia & Pain Medicine 2021;46:840-859. https://rapm.bmj.com/cont…

24. September 2021 | Buprenorphin

Polysubstance Use Among Patients Treated With Buprenorphine From a National Urine Drug Test Database.

Polysubstance Use Among Patients Treated With Buprenorphine From a National Urine Drug Test Database. Saloner B, Whitley P, LaRue L, Dawson E, Huskey A. JAMA Netw Open. 2021;4(9):e2123019. doi:10.1001/jamanetworkopen.2021.23019 h…

24. September 2021 | Buprenorphin

Clinical guidelines for use of depot buprenorphine (Buvidal® and Sublocade®) in the treatment of opioid dependence.

Clinical guidelines for use of depot buprenorphine (Buvidal® and Sublocade®) in the treatment of opioid dependence. Lintzeris N, Dunlop A, Masters D (2019) NSW Ministry of Health, Sydney Australia https://www.health.nsw.gov.au/aod/Pub…

06. September 2021 | Buprenorphin

Transition from methadone to subcutaneous buprenorphine depot in patients with opioid use disorder in custodial setting - a case series.

Transition from methadone to subcutaneous buprenorphine depot in patients with opioid use disorder in custodial setting - a case series. Soyka M, Groß G. Am J Drug Alcohol Abuse. 2021 Aug 18:1-6. doi: 10.1080/00952990.2021.1963757. Epub ahead…

06. September 2021 | Buprenorphin

Beneficial Effects of Opioid Rotation to Buprenorphine/Naloxone on Opioid Misuse, Craving, Mental Health, and Pain Control in Chronic Non-Cancer Pain Patients with Opioid Use Disorder.

Beneficial Effects of Opioid Rotation to Buprenorphine/Naloxone on Opioid Misuse, Craving, Mental Health, and Pain Control in Chronic Non-Cancer Pain Patients with Opioid Use Disorder. Schellekens AFA, Veldman SE, Suranto ESD, van Rijswijk SM…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten